Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000246776 | SCV000305082 | benign | not specified | 2016-08-15 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000284169 | SCV000412684 | likely benign | Central core myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000339185 | SCV000412685 | likely benign | Neuromuscular disease, congenital, with uniform type 1 fiber | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000375049 | SCV000412686 | likely benign | Malignant hyperthermia of anesthesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000280576 | SCV000412687 | likely benign | Multiminicore myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000246776 | SCV000525210 | benign | not specified | 2016-10-31 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000544758 | SCV000660098 | benign | RYR1-related disorder | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004703520 | SCV005207174 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Color Diagnostics, |
RCV005402895 | SCV006064094 | benign | Malignant hyperthermia, susceptibility to, 1 | 2022-10-03 | criteria provided, single submitter | clinical testing |